2012 Washington Initiative 502

From WikiMD's Food, Medicine & Wellness Encyclopedia


Washington Initiative 502 (I-502) was a landmark piece of legislation passed in the state of Washington in November 2012. The initiative legalized the recreational use of cannabis for adults age 21 and older, marking a significant shift in the legal landscape of cannabis policy in the U.S. This article provides an overview of the initiative, its implications, and its impact on the state of Washington and beyond.

Background[edit | edit source]

Prior to the passage of I-502, cannabis was illegal for recreational use across the United States, including in Washington. The use, possession, and sale of cannabis were subject to criminal penalties. The movement towards legalization gained momentum in the early 21st century, with advocates arguing for the medical benefits of cannabis, the economic benefits of regulation and taxation, and the social justice benefits of reducing drug-related arrests and convictions.

Provisions of I-502[edit | edit source]

I-502 contained several key provisions aimed at regulating the production, sale, and use of cannabis. These included:

  • Establishing a system for the licensing of cannabis producers, processors, and retailers by the Washington State Liquor and Cannabis Board.
  • Imposing a 25% excise tax at each stage of sale, from producer to processor to retailer, with revenues intended to support public health programs, substance abuse prevention, and education.
  • Setting limits on possession for personal use to one ounce of dried cannabis, 16 ounces of cannabis-infused product in solid form, or 72 ounces in liquid form.
  • Prohibiting cannabis consumption in public and driving under the influence of cannabis, with a set blood THC concentration limit for DUI enforcement.

Impact[edit | edit source]

The passage of I-502 had a significant impact on the state of Washington and served as a model for other states considering cannabis legalization. Key impacts include:

  • A substantial increase in state revenue from taxes and fees associated with cannabis sales.
  • A decrease in arrests and convictions for cannabis-related offenses, contributing to discussions on criminal justice reform and social equity.
  • The establishment of a regulated market that has contributed to research on cannabis and its effects.

Controversies and Challenges[edit | edit source]

Despite its successes, the implementation of I-502 has faced challenges and controversies, including:

  • Concerns from some communities about increased access to cannabis and potential impacts on public health and safety.
  • Legal and regulatory challenges, including issues related to banking and federal law, which still classifies cannabis as a Schedule I controlled substance.
  • The need for ongoing adjustments to regulatory frameworks to address issues such as product testing standards and the integration of medical and recreational cannabis markets.

Conclusion[edit | edit source]

Washington Initiative 502 represented a significant shift in cannabis policy, not only for the state of Washington but also as a precedent for other states and countries. Its passage reflected changing attitudes towards cannabis and has had wide-ranging implications for law, public health, and social justice.


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD